‎AME shareholders okay dividend payout, termination of current board

‎AME shareholders okay dividend payout, termination of current board ‎AME shareholders okay dividend payout, termination of current board

​‎

Logo ofAME Company for Medical Supplies

AME Company for Medical Supplies’ shareholders approved the board recommendation to distribute a 20% cash dividend (SAR 2 per share) for 2024, during an extraordinary general meeting (EGM) held on May 25.

Advertisement

Dividend Details (2024)​

Current Capital

SAR 70 mln

No. of Shares

7 mln

Share Par Value

SAR 10

Total Dividend

SAR 14 mln

Percentage of Capital

20% (SAR 2 per share)​

Record Date

May 25, 2025 – Shareholders of record and those registered with the Securities Depository Center Co. (Edaa) by the end of the second trading day after the deciding EGM

Payment Date

June 11, 2025

For more news on listed companies

In a statement toTadawul, the shareholders also decided the early termination of the current board prior to the end of the current term on July 30, 2025.

 

Logo ofAME Company for Medical Supplies

AME Company for Medical Supplies’ shareholders approved the board recommendation to distribute a 20% cash dividend (SAR 2 per share) for 2024, during an extraordinary general meeting (EGM) held on May 25.

Dividend Details (2024)​

Current Capital

SAR 70 mln

No. of Shares

7 mln

Share Par Value

SAR 10

Total Dividend

SAR 14 mln

Percentage of Capital

20% (SAR 2 per share)​

Record Date

May 25, 2025 – Shareholders of record and those registered with the Securities Depository Center Co. (Edaa) by the end of the second trading day after the deciding EGM

Payment Date

June 11, 2025

For more news on listed companies

In a statement toTadawul, the shareholders also decided the early termination of the current board prior to the end of the current term on July 30, 2025.

Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Keep Up to Date with our Weekly Newsletter

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Advertisement